AVR

0.00%

$18.00 anteris technologies ltd

Thanks for posting that info Tuppy, very interesting reading.

First 26 Last

Share
Profile

Follow
quacker

839 Posts.

41

03/10/14

16:15

Post #: 14072642
Share

Originally posted by tuppy ↑

An excerpt below talking about Gardasil studies to put things in perspective. Much bigger operation by the looks of things but similar looking results from early studies indicating dose dependant response.

Full story can be found here: http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4222B3.pdf

Phase 1 and Phase 2 Studies

Merck conducted six phase 1 and phase 2 clinical studies between 1997 and 2004. Four smaller phase 1 or early phase 2 studies evaluated monovalent HPV VLP vaccines, serotypes 11, 16, or 18, in order to characterize safety and immune responses among different doses. Two larger phase 2 studies were conducted between 2000 and 2004 that included clinical endpoints in addition to the safety and immune response endpoints. The results of these studies were used to identify appropriate dose and endpoints to be used in the phase 3 pivotal studies. The studies suggested an acceptable safety profile for further clinical development. The larger phase 2 studies provided supportive evidence of vaccine activity. The applicant’s clinical development program focused on a three-dose regimen at months 0, 2, and 6 based on previous clinical and immunological experiences with their hepatitis B vaccine product.

Studies 001, 002, and 006 were small phase 1 safety studies that evaluated the monovalent HPV VLP serotypes 11, 16, and 18, respectively. Studies 001 and 002 enrolled 249 subjects, and approximately 200 received the vaccine. The results demonstrated a “dose response”, where higher doses generally resulted in larger post-vaccination geometric mean titers. Overall, the immune responses in subjects who received the 20 μg, 40 μg, or 50μg dose were better than the immune responses in subjects who received the 10 μg dose. There appeared to be no advantage in immune responses to an 80 μg dose, or to the administration of a fourth dose.

Expand

Thanks for posting that info Tuppy, very interesting reading.

AHZ Price at posting: 14.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

ASX hits all time high out the gate on Friday trades following bullish US inflation data

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Bitcoin investors need to know the risks

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

There are more pages in this discussion • 34 more messages in this thread...

First 26 Last

Add AVR (ASX) to my watchlist

(20min delay)
Last $18.00		Change 0.000(0.00%)		Mkt cap ! $346.0M

Open	High	Low	Value	Volume
$18.00	$18.10	$17.70	$58.64K	3.27K

Buyers (Bids)

No.	Vol.	Price($)
1	109	$18.00

Sellers (Offers)

Price($)	Vol.	No.
$18.10	700	1

View Market Depth

No.	Vol.	Price($)
1	48	17.750
1	26	17.650
1	200	17.560
1	500	17.550
1	1	17.510

Price($)	Vol.	No.
18.100	700	1
18.300	150	1
18.500	43	1
18.690	550	1
18.750	143	1

Last trade - 16.10pm 12/07/2024 (20 minute delay)

AVR (ASX) Chart

Thanks for posting that info Tuppy, very interesting reading.

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Immutep reports strong response rate from immunotherapies treating carcinomas

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Bitcoin investors need to know the risks

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Nimy to raise $1.21M to explore 'newsy' WA targets

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks for posting that info Tuppy, very interesting reading.

Top Stories

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Immutep reports strong response rate from immunotherapies treating carcinomas

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Bitcoin investors need to know the risks

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Nimy to raise $1.21M to explore 'newsy' WA targets

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News